Synmosa Biopharma Corporation (TPEX:4114) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 ordinary shares, representing 1.28% of the issued share capital, for a total of TWD 1,177.47 million. The shares will be repurchased within the price range of TWD 17.5 per share to TWD 36.5 per share.

The program will expire on May 29, 2022. As of March 29, 2022, the company has 13,519,000 shares in treasury.